By understanding the data on cancer in Yorkshire we can pinpoint which types each area predominately suffers from and why.
This allows us to correctly target different areas, reducing inequalities by lowering the risk of developing cancer, improving early diagnosis and raising the quality of treatment.
We work in partnership with researchers, scientists and clinicians, the NHS, Public Health England and other health organisations and charities to make life-changing improvements.
Testing solutions allows us to continue funding research and initiatives which produce the best clinical outcomes across our region.
We’re committed to investing £100m over the next 10 years to tackle Yorkshire’s biggest cancer problems.
By measuring the impact of every initiative we can ensure that we’re helping to create the best outcomes possible.
Become a leading authority on regional cancer-related issues so that Yorkshire people are amongst the best-informed in England.
Educate and influence lifestyle choices that reduce the risk of cancer or support recovery from it.
Encourage the earliest diagnosis possible, increase screening rates, improve services and develop more effective techniques and practices.
Invest in research-led innovation at every stage of cancer from diagnosis through to treatment, clinical trials, palliative and end of life care.
Help deliver better cancer services and significantly increase national research funding specifically to improve cancer outcomes in our region.
We strive for excellence in everything we do, working efficiently to drive results.
By being reliable and professional at all times.
The Association of Medical Research Charities (AMRC) is a membership organisation of the leading medical and health research charities in the UK. Working with member charities and partners, they aim to support the sector’s effectiveness and advance medical research by developing best practice, providing information and guidance, improving public dialogue about research and science, and influencing government.
The Fundraising Regulator is the independent regulator of charitable fundraising. It was established following the Etherington review of fundraising self-regulation (2015) to strengthen the system of charity regulation and restore public trust in fundraising.
Yorkshire Cancer Research has registered with the Fundraising Regulator to show our commitment to best practice in fundraising and support the Code of Fundraising Practice.
As part of our strategy, we set clear priorities and measure our achievements against them. Yorkshire Cancer Research’s research advisory panel confirms the quality and relevance of all research that is referred to the general guidance on public benefit when reviewing our activities against the objectives we set ourselves and in planning future activities. Yorkshire Cancer Research aims to fund the best quality scientific research into the causes and cures of cancer. We aim to provide a broad mix of scientific awards that gives our researchers the best chance of finding breakthroughs. We will also encourage other funders of cancer research to support world-class Yorkshire scientists and clinicians. We will ensure that the next generation of scientific leaders are being developed.
Yorkshire Cancer Research is a member of the Association of Medical Research Charities (AMRC). We support the principle of using animals in research when it is necessary to advance understanding of health and disease and to develop new treatments. This research only takes place where there is no alternative available. All AMRC member charities support this principle as outlined in this statement:
Our focus is on research which delivers benefit for people and patients in and beyond the Yorkshire region. In our last four funding rounds, no research work involving animals has been funded, and we are unlikely to fund research work involving animals in the future based on our current published strategy. We expect that within two years our research portfolio will not contain any projects which are undertaking work involving animals.
Visit our contact preferences.